Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Efficacy Results from a Randomized, Double-Blind, Placebo-Controlled Study

OBJECTIVE: To test the efficacy of adjunctive ziprasidone in adults with non-psychotic unipolar major depression experiencing persistent symptoms following 8 weeks of open-label escitalopram. METHOD: This was a multi-center, parallel randomized, double-blind, placebo-controlled trial conducted at th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Psychiatry
Main Authors: Papakostas, George I., Fava, Maurizio, Baer, Lee, Swee, Michaela B., Jaeger, Adrienne, Bobo, William V., Shelton, Richard C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4843798/
https://ncbi.nlm.nih.gov/pubmed/26085041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1176/appi.ajp.2015.14101251
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados